RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

69 hedge funds and large institutions have $84.5M invested in Regulus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 11 closing their positions.

Holders
69
Holders Change
-1
Holders Change %
-1.43%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
22
Reduced
16
Closed
11
Calls
$38K
Puts
$11K
Net Calls
+$27K
Net Calls Change
-$81K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$3.46M
2
OCA
2
Octagon Capital Advisors
New York
$7.66M
3
BlackRock
3
BlackRock
New York
$6.69M
4
Citadel Advisors
4
Citadel Advisors
Florida
$246K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$301K

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$47K
2
WP
2
Woodline Partners
California
$0
3
OM
3
Opaleye Management
Massachusetts
$0
4
RCM
4
RA Capital Management
Massachusetts
$532K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$8.78K
Name Holding Trade Value Shares
Change 		Shares
Change %
AQR Capital Management
76
AQR Capital Management
Connecticut
– -$47.4K -30,209 Closed
Jane Street
77
Jane Street
New York
– -$46.4K -29,580 Closed
HSBC Holdings
78
HSBC Holdings
United Kingdom
– -$29.7K -19,224 Closed
GC
79
Grimes & Company
Massachusetts
– -$17.2K -10,975 Closed
1 2 3
4